m
Our Mission Statement
This is Photoshop's version of Loremer Ipsn gravida nibh vel velit auctoregorie sam alquet.Aenean sollicitudin, lorem quis bibendum auci elit consequat ipsutis sem nibh id elit.
Follow Us
Top
Who We Are – Transcell
6668
page-template,page-template-full-width,page-template-full-width-php,page,page-id-6668,mkd-core-1.0,highrise-ver-1.0,,mkd-smooth-page-transitions,mkd-ajax,mkd-grid-1300,mkd-blog-installed,mkd-header-vertical,mkd-sticky-header-on-scroll-up,mkd-default-mobile-header,mkd-sticky-up-mobile-header,mkd-dropdown-slide-from-bottom,mkd-dark-header,mkd-full-width-wide-menu,mkd-search-dropdown,mkd-side-menu-slide-from-right,wpb-js-composer js-comp-ver-5.0.1,vc_responsive
 

Who We Are

Transcell Oncologics has dedicated team working on

  • Real time throughput screening of toolbox based novel complex compounds
  • Genomics of Indian cancer patients sourced cancer stem cells based platforms exposed to druggable molecules
  • Hunting for undruggable challenging targets in cancers for druggable molecules
  • Elucidating novel mechanistic pathways leading to known targets modulated by small molecules
  • Drug discovery from the insights of cancer genomics

As a stem cell based biotech company, we uniquely leverage our distinct insights from adult stem cells sourced from patients samples, donor samples, predictive stem cell technologies to discover the anti-cancer stem/cell properties, hunting for druggable molecules that selectively kill cancer stem cells. The data on human/patient based platforms/models, Genomics and Proteomics aid to advance our pipeline to clinical proof of concept and discovery of functional molecules. Access to all new nature inspired complex macrocyclic small molecules along with the wisdom derived from the stem cell technologies are our differentiating positioning in this space accelerating the process of drug discovery in Oncology.


R & D Team

S Dravida, PhD


S Dravida leads the team and collaborations responsible for discovering druggable formulations across therapeutic areas and platforms. Her role requires converging and executing both laboratory, clinical research programs across touch points.

Past Affiliations:

  • University of North Carolina, Ottawa Health Research Institute,
  • Center for Cellular and Molecular Biology, Hyderabad Eye Research Foundation.

Expertise: Adult stem cell technologies, Predictive platform development and screening, Primary cells, Tumorospheres, Low throughput and High throughput platform technologies, Cancer progenitor cells, Repository of patient sourced screening platforms, Cell based readouts, Drug discovery, pre-discovery process

S Dravida is the inventor of Transcell’s proprietary technologies and has authored or co-authored peer-reviewed research publications in the same domain of practice.


Madhumohan Rao K, PhD

Past Affiliations :

  • 2016 Aug – 2017 Aug: Sandor Life sciences,India
  • 2016 April – Aug 2016: Erlangen university and BoehringerIngelheim GmbH, Germany
  • Sep 2014– Present: Medical Cell Biophysics Twente university the Netherlands and JNJ oncology USA
  • 2012-2014 Feb: Breast cancer group Center for molecular medicine Norway
  • 2012-2014 Feb: Dept of genetics, Oslo hospital, Norway
  • 2011-2012 March: RIKILT, Wageningen, the Netherlands
  • 2007 -2011 September: PhD in Immunotoxicogenomics, RIKILT, Wageningen and University of Maastricht, the Netherlands.
  • 2006-07: Guest researcher (Maastricht University hospital, the Netherlands)
  • 2005-2006: Research assistant (Center for DNA Fingerprinting and Diagnostics, India)

Expertise: Molecular cell biology, Cancer genomics, Single cell genomics, Molecular genetics, Immuno-oncology, Invitro bioassays, Stem cells, Liquid biopsies and Toxicology


Adeel Husain Zaidi, PhD

Past Affiliations:

  • Doctor of Philosophy (Ph.D.) 2009–2016
  • Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad

Expertise:
Molecular biology, Biochemistry, Transformed cell lines, Cell signal biology, Transduction, Biophysics, Auto-dock, Translational Research


Ranjith Kumar Indarapu, PhD

Past Affiliations :

  • Quality Control Microbiologist: May 2011 – May 2012, Chromogenic Life Sciences
  • Medical Microbiologist: May 2010 – May 2011, Path care Labs

Expertise: Explant tissue cultures, Mammalian primary cells, Bio-equipmentation, Process validation, Quality control and assurance, Clean rooms process


Toolbox Chemistry

Natural product-inspired 3D architectures, Bioactive natural products with sufficient complexity, Scalable synthesis processes, functionalized macrocyclic compounds with large surface area, first-in-class small molecules, next generation druggable for challenging targets, Scaffolds having indole- and tetrahydroquinoline-inspired alkaloids, benzofuran- and benzopuran-inspired polyphenolics.